Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 17, 2018

DrugPatentWatch Database Preview

Watson Pharms Teva Company Profile

« Back to Dashboard

What is the competitive landscape for WATSON PHARMS TEVA, and what generic and branded alternatives to WATSON PHARMS TEVA drugs are available?

WATSON PHARMS TEVA has nine approved drugs.

Summary for Watson Pharms Teva

US Patents:	0
Tradenames:	6
Ingredients:	5
NDAs:	9

Drugs and US Patents for Watson Pharms Teva

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Pharms Teva	ZOVIA 1/35E-21	ethinyl estradiol; ethynodiol diacetate	TABLET;ORAL-21	072720-001	Dec 30, 1991		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Watson Pharms Teva	AMOXAPINE	amoxapine	TABLET;ORAL	072421-001	May 11, 1989		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Watson Pharms Teva	ATRACURIUM BESYLATE	atracurium besylate	INJECTABLE;INJECTION	074945-001	Jul 28, 1998		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Watson Pharms Teva	AMOXAPINE	amoxapine	TABLET;ORAL	072418-001	May 11, 1989		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Watson Pharms Teva	AMOXAPINE	amoxapine	TABLET;ORAL	072419-001	May 11, 1989		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Watson Pharms Teva	NORETHINDRONE AND ETHINYL ESTRADIOL	ethinyl estradiol; norethindrone	TABLET;ORAL-21	070685-001	Jan 29, 1987		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Watson Pharms Teva	RIFAMPIN	rifampin	INJECTABLE;INJECTION	206736-001	Jan 19, 2016	AP	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School

Colorcon

AstraZeneca

Cipla

Dow

Merck

Teva

Express Scripts

Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.